about
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemiviba...
Read More
0.74
-0.05
(-6.33%)
2.1M
XNAS Volume
XNAS 17 Jul, 2026 4:06 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks have poor scores across the board. Investors should be very cautious with these stocks
View Similar
Embed DVM
Invivyd Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..